In a historic move to transform malaria prevention and strengthen health security in Nigeria, Vestergaard Sàrl and Harvestfield Industries Limited today marked the ground-breaking of their first-of-its-kind joint venture for mosquito net manufacturing in Nigeria.
The new entity, named SNG Health, will operate the factory located in Ogun State. It is set to produce PermaNet® Dual, which is Vestergaard’s latest dual active-ingredient net containing pyrethroid and chlorfenapyr.
This net is specifically designed to combat growing insecticide resistance. Manufacturing at the state-of-the-art facility is scheduled to begin in April 2026. Once fully operational, the factory will have an at-scale annual capacity of 10 million nets. Furthermore, the investment is expected to create 600 skilled jobs, which will strengthen local expertise and industrial capacity.
The ceremony was attended by key stakeholders, including Dr. Abdu Mukhtar (National Coordinator, PVAC), Dr. Godwin Ntadom (Director of Public Health, Federal Ministry of Health and Social Welfare), Dr. Nnenna Ogbulafor (National Coordinator, National Malaria Elimination Programme), Ms. Cornelia Camenzind (Consul General of Switzerland in Lagos), and Mr. Onoriode Ezire (Task Team Leader, World Bank Nigeria).
Nigeria carries the world’s highest malaria burden, accounting for a quarter of all global cases. New data confirms the efficacy of life-saving tools like insecticide-treated nets, which have been responsible for 72% of all malaria cases prevented globally between 2000 and 2024. Dual active-ingredient nets, including PermaNet Dual, alone stopped 40 million cases from 2019 to 2024.
Dr. Abdu Mukhtar, National Coordinator of the President’s Value Chain Initiative (PVAC), highlighted the strategic importance of the factory: “Nigeria is signalling that we are ready to lead the next frontier of malaria control in West Africa. This facility is a direct outcome of the Federal Government’s commitment to industrialize our health sector and anchor critical health products within the country. Every mosquito net produced here represents a Nigerian job, a Nigerian skill strengthened, and value created within our economy.”
The ground-breaking turns the March 2024 Yaoundé Declaration pledge that no one should die from malaria, given the tools and systems available, into tangible action.
Amar Ali, CEO of Vestergaard, emphasized the long-term nature of the partnership: “This facility embodies Vestergaard’s commitment to long-term partnership with Nigeria… By directly investing in local production of PermaNet Dual and putting our brand’s reputation behind this venture—we are not only delivering world-class innovation, but also ensuring families across Nigeria have quality protection against malaria.
Martins Awofisayo, CEO of Harvestfield Industries, focused on the impact on industrial capacity: “Today marks an important step in strengthening Nigeria’s health security and industrial capacity. By partnering with Vestergaard to establish this facility in Nigeria, we are creating a reliable local source of world-class mosquito nets that will support malaria prevention efforts across the country.”
Prosper Ndayiragije, Managing Director of SNG Health, concluded that this new chapter underscores Nigeria’s commitment to defeating malaria and ensuring that no Nigerian family endures the burden of the disease in the future.
Key Highlights
- A comprehensive 10-year strategic partnership focused on transforming Nigeria’s healthcare infrastructure with cutting-edge medical imaging technology and extensive capacity-building.
- The initial phase will see Siemens Healthineers equip 10 new MedServe diagnostic centers nationwide, substantially improving access to high-quality care.
- The agreement emphasizes sustainable development through world-class technology, comprehensive training, and the enhancement of local expertise.
This long-term agreement is centered on advancing diagnostic capabilities across the country by providing state-of-the-art medical imaging technology and capacity-building initiatives to ensure sustainable support for MedServe’s healthcare expansion program. To commence the partnership, Siemens Healthineers will equip the 10 new MedServe centers that are soon to be operational nationwide, facilitating greater access to high-quality medical imaging for the Nigerian people.
Dr. Tolulope Adewole, MD & CEO, NSIA Advanced Medical Services (MedServe), underscored the significance of the deal: “This 10-year partnership with Siemens Healthineers is a pivotal step in our strategic mission to build a resilient and sustainable advanced healthcare system that provides equitable access for Nigerians. We are consolidating our relationship with a trusted technology leader to not only supply critical equipment but also to develop local expertise. This initial deployment across our 10 new sites is the beginning of a shared journey to enhance diagnostic access and improve clinical outcomes across our nation.”
Dr. Bernd Ohnesorge, President, Europe, Middle East and Africa (EMEA), Siemens Healthineers, expressed honor in expanding the partnership: “Having already established a strong collaboration in oncology, we are proud to extend our joint efforts into diagnostic imaging. This strategic agreement reflects our shared, long-term commitment to the future of Nigerian healthcare. We will support NSIA with world-class technology, comprehensive training, and our full expertise across medical imaging and oncology care systems to ensure this initiative delivers a lasting, positive impact for Nigerians.”
MedServe remains committed to delivering equitable healthcare access to Nigerians through strategic partnerships, capacity enhancement, and healthcare infrastructure investments.
Siemens Healthineers is a global provider of healthcare equipment, solutions, and services, active in more than 180 countries. Listed as SHL in Frankfurt, Germany, the company is committed to improving access to healthcare for underserved communities worldwide and is principally active in imaging, diagnostics, cancer care, and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, the company generated revenue of around €23.4 billion with approximately 74,000 employees globally.
The Nigeria Sovereign Investment Authority (NSIA) is an investment institution of the Federal Republic of Nigeria established to manage and invest in a diversified portfolio of medium and long-term funds. Its mission is to drive sustained economic development for the benefit of all Nigerians through building a savings base, enhancing infrastructure development, and providing economic stabilization support. NSIA operates three distinct funds: the Stabilisation Fund, the Future Generations Fund, and the Nigeria Infrastructure Fund.